Pharmacokinetic targeting of intravenous busulfan reduces conditioning regimen related toxicity following allogeneic hematopoietic cell transplantation for acute myelogenous leukemia
<p>Abstract</p> <p>Optimal conditioning therapy for hematopoietic cell transplantation (HCT) in acute myelogenous leukemia (AML) remains undefined. We retrospectively compared outcomes of a consecutive series of 51 AML patients treated with oral busulfan (1 mg/kg every 6 hours for...
Main Authors: | Nishihori Taiga, Kharfan-Dabaja Mohamed A, Anasetti Claudio, Kim Jongphil, Pidala Joseph, Field Teresa, Perkins Janelle, Perez Lia, Fernandez Hugo F |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-10-01
|
Series: | Journal of Hematology & Oncology |
Online Access: | http://www.jhoonline.org/content/3/1/36 |
Similar Items
-
Role of reduced intensity conditioning in allogeneic hematopoietic cell transplantation for patients with multiple myeloma
by: Taiga Nishihori, et al.
Published: (2011-01-01) -
Busulfan and melphalan as conditioning regimen for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia in first complete remission
by: Nadjanara Dorna Bueno, et al.
Published: (2011-06-01) -
Comparative efficacy of tandem autologous versus autologous followed by allogeneic hematopoietic cell transplantation in patients with newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trials
by: Kharfan-Dabaja Mohamed A, et al.
Published: (2013-01-01) -
Conditioning regimen using busulfan plus melphalan in hematopoietic stem cell transplantation: can this conditioning regimen be used in autologous or allogeneic transplantation for acute leukemia?
by: Roberto M Lemoli, et al.
Published: (2011-06-01) -
Economic Impact of Pharmacokinetic Monitoring on the use of Oral and Intravenous Busulfan in Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
by: Karpen, Stephen, et al.
Published: (2014)